V. Magri, S. Scagnoli, G. Piesco, and G. Pomati, “Lapatinib as second-line treatment after the double block pertuzumab-trastuzumab: a case report: Lapatinib in II linea dopo il doppio blocco pertuzumab-trastuzumab: un caso clinico”, AboutOpen, vol. 4, no. 1, pp. 185–190, Oct. 2018.